JAZZ
Jazz Pharmaceuticals plc
Stock
$235.67+2.66 (+1.14%)Close Oct 2, 2026
- EBITDA, 2025
- −$389M
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | −$389M | — |
| 2024 | $749M | +23.1% |
| 2023 | $609M | — |
| 2022 | −$35M | — |
| 2021 | $197M | −50.3% |
| 2020 | $397M | −27.6% |
| 2019 | $548M | −13.1% |
| 2018 | $630M | +16.3% |
| 2017 | $542M | −10.2% |
| 2016 | $603M | +16.5% |
| 2015 | $518M | +155.6% |
| 2014 | $203M | −41.0% |
| 2013 | $343M | +72.4% |
| 2012 | $199M | +55.3% |
| 2011 | $128M | +118.5% |
| 2010 | $59M | +238.0% |
| 2009 | $17M | — |